(Reuters) – Merck & Co Inc on Thursday reported a 49% fall in second-quarter profit after it spun off its women’s health and biosimilar assets into Organon in June.
(Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)
Merck profit nearly halves on Organon spin off
Peoria, IL, USA
68 °F Thunderstorm In Vicinity
